Airline Industry Today
SEE OTHER BRANDS

Fresh airlines and aviation news from the world

Airline Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Airline Industry Today.

Press releases published on April 28, 2025

Foghorn Therapeutics Presents New Preclinical Data on Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Programs and Provides Pipeline Update

Foghorn Therapeutics Presents New Preclinical Data on Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Programs and Provides Pipeline Update

- FHD-909 (LY4050784) advancing in Phase 1 trial in SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population - Preclinical synergistic anti-tumor activity of FHD-909 in combination with pembrolizumab and KRAS …

LifeMD to Report First Quarter 2025 Financial Results on May 6

LifeMD to Report First Quarter 2025 Financial Results on May 6

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2025 after the close of the U.S. financial …

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates

SINGAPORE, April 28, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel …

Tempest Presents New Amezalpat MOA Data Reinforcing Its Potential as Novel Cancer Treatment at the 2025 AACR Annual Meeting

Tempest Presents New Amezalpat MOA Data Reinforcing Its Potential as Novel Cancer Treatment at the 2025 AACR Annual Meeting

BRISBANE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced that a presentation …

Clearway Signs 335 MW Power Purchase Agreement with Microsoft

Clearway Signs 335 MW Power Purchase Agreement with Microsoft

SAN FRANCISCO, April 28, 2025 (GLOBE NEWSWIRE) -- Clearway Energy Group (“Clearway”) has signed a long-term power purchase agreement (PPA) with Microsoft for the 335 megawatt (MW) Mount Storm wind farm located in Grant County, West Virginia. Mount Storm …

Kane Biotech Announces Fourth Quarter and Full Year 2024 Financial Results, Narrows Strategic Focus and Makes Leadership Change

Kane Biotech Announces Fourth Quarter and Full Year 2024 Financial Results, Narrows Strategic Focus and Makes Leadership Change

WINNIPEG, Manitoba, April 28, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) today announced its fourth quarter and full year 2024 financial results. Fourth Quarter 2024 Financial Highlights ( …

VirTra Sets First Quarter 2025 Conference Call for Monday, May 12, 2025 at 4:30 p.m. ET

VirTra Sets First Quarter 2025 Conference Call for Monday, May 12, 2025 at 4:30 p.m. ET

CHANDLER, Ariz., April 28, 2025 (GLOBE NEWSWIRE) -- VirTra, Inc. (Nasdaq: VTSI) (“VirTra” or the “Company”), a global provider of judgmental use of force training simulators and firearms training simulators for the law enforcement and military markets, …

The Aqua Sculpt Truth Revealed About Cold Ice Water Diet Hack Recipe

The Aqua Sculpt Truth Revealed About Cold Ice Water Diet Hack Recipe

New York, April 28, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: The science behind the Aqua Sculpt Ice Water Hack and how cold water may naturally boost metabolism through thermogenesis A detailed Aqua Sculpt ingredients list with …

Bicara Therapeutics Highlights Broad Potential of Ficerafusp Alfa at AACR Annual Meeting 2025

Bicara Therapeutics Highlights Broad Potential of Ficerafusp Alfa at AACR Annual Meeting 2025

BOSTON, April 28, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced multiple presentations …

Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call

Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call

ROMEOVILLE, Ill., April 28, 2025 (GLOBE NEWSWIRE) -- Romeoville, Ill., April 28, 2025 – Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will …

Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer

Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer

CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial …

Astec Announces Quarterly Dividend

Astec Announces Quarterly Dividend

CHATTANOOGA, Tenn., April 28, 2025 (GLOBE NEWSWIRE) -- Astec Industries, Inc. (NASDAQ: ASTE) announced that its Board of Directors declared a quarterly dividend of $0.13 per share. The dividend is to be paid on or about May 30, 2025, to shareholders of …

MYR Group Inc. to Attend KeyBanc Industrials & Basic Materials Conference in May

MYR Group Inc. to Attend KeyBanc Industrials & Basic Materials Conference in May

THORNTON, Colo., April 28, 2025 (GLOBE NEWSWIRE) -- MYR Group Inc. (“MYR Group”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial construction markets in the United …

Woodward Reports Second Quarter Fiscal Year 2025 Results

Woodward Reports Second Quarter Fiscal Year 2025 Results

~Results in Line with Expectations, on Track to Deliver Full-Year Guidance~ FORT COLLINS, Colo., April 28, 2025 (GLOBE NEWSWIRE) -- Woodward, Inc. (NASDAQ: WWD) today reported financial results for its second quarter of fiscal year 2025. All amounts are …

CytomX Therapeutics Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna at AACR Annual Meeting

CytomX Therapeutics Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna at AACR Annual Meeting

SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced new preclinical data in collaboration with Moderna on an mRNA …

Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders

Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders

TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 Annual Meeting of Shareholders on Friday, June 20, 2025, at 11:00 a.m. ET. Cronos will be conducting the meeting in a …

Core Molding Technologies Announces Timing of First Quarter Fiscal 2025 Results

Core Molding Technologies Announces Timing of First Quarter Fiscal 2025 Results

COLUMBUS, Ohio., April 28, 2025 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building …

Nurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs

Nurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs

Nurix’s DEL-AI platform uses a first-in-class DEL Foundation Model trained on the Company’s proprietary DNA encoded library data Nurix’s DEL Foundation Model can accurately predict novel binders to therapeutically relevant targets, including many targets …

Slimjaro Side Effects Reviewed: Discover the Shocking Truth About Ingredients, Benefits & Customer Results

Slimjaro Side Effects Reviewed: Discover the Shocking Truth About Ingredients, Benefits & Customer Results

New York, April 28, 2025 (GLOBE NEWSWIRE) -- TL;DR: Slimjaro Side Effects Reviewed Slimjaro is a natural, non-GMO weight loss supplement developed for individuals committed to achieving sustainable fitness and wellness goals over 3, 6, or 12 months. In …

Building a Home on Your Own Land: HelloNation Calls Robert Steele of S.S. Steele Expert on Lot-Based Home Construction in Mobile, AL

Building a Home on Your Own Land: HelloNation Calls Robert Steele of S.S. Steele Expert on Lot-Based Home Construction in Mobile, AL

MOBILE, Ala., April 28, 2025 (GLOBE NEWSWIRE) -- Understanding what goes into building a home on your own lot can significantly reduce uncertainty and lead to a more successful outcome. This is especially true for families in Mobile, Alabama, where local …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service